Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Cancer Medicine
|
April 16, 2023
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival
Kevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2024
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier
Yi Song, Thomas Boerner, Esther Drill, et al.
Liver Cancer
|
March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
Radiology
|
February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-Fluoroglutamine
Mark P S Dunphy, James J Harding, Sriram Venneti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2021
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
Joshua S Jolissaint, Kevin C Soares, Kenneth P Seier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
Annals of Surgical Oncology
|
October 9, 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, et al.
JCO Precision Oncology
|
September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology
Jessica J Tao, Michael H Eubank, Alison M Schram, et al.
The Oncologist
|
March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
The Journal of Clinical Investigation
|
July 23, 2019
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
Danny N Khalil, Nathan Suek, Luis Felipe Campesato, et al.
Cancer Medicine
|
April 16, 2023
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival
Kevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2024
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier
Yi Song, Thomas Boerner, Esther Drill, et al.
Liver Cancer
|
March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
Radiology
|
February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-Fluoroglutamine
Mark P S Dunphy, James J Harding, Sriram Venneti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2021
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
Joshua S Jolissaint, Kevin C Soares, Kenneth P Seier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
Annals of Surgical Oncology
|
October 9, 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, et al.
JCO Precision Oncology
|
September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology
Jessica J Tao, Michael H Eubank, Alison M Schram, et al.
The Oncologist
|
March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
Page
of 14